A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemia.

Am J Hematol

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Published: November 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932338	PMC
http://dx.doi.org/10.1002/ajh.25968	DOI Listing

Publication Analysis

phase study

study ibrutinib

ibrutinib short-course

short-course fludarabine

fludarabine untreated

untreated patients

patients chronic

chronic lymphocytic

lymphocytic leukemia

phase

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!